Levosimendan in High Risk Heart Valve Surgery

• Status: Completed
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Prospective, randomized, double blind study investigating the efficacy of levosimendan in heart failure after cardiac surgery.

Study hypothesis: Levosimendan diminishes the need for adrenergic inotropic drugs and morbidity and may improve survival after heart valve surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kuopio University Hospital
• Treatments: Simendan

Criteria

Inclusion Criteria:

Eligible for cardiac valve or combined CABG and cardiac valve surgery:

• Clinical signs of cardiac insufficiency

Exclusion Criteria:

• Endocarditis